A Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts
A Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts
通過7位分析師的觀點了解艾伯維公司的專家前景
7 analysts have expressed a variety of opinions on AbbVie (NYSE:ABBV) over the past quarter, offering a diverse set of opinions from bullish to bearish.
過去一個季度，7位分析師對AbbVie (NYSE:ABBV)發表了不同的看法，從看好到看淡意見不一。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
Analysts have recently evaluated AbbVie and provided 12-month price targets. The average target is $190.29, accompanied by a high estimate of $200.00 and a low estimate of $180.00. Observing a downward trend, the current average is 1.4% lower than the prior average price target of $193.00.
分析師近期評估了AbbVie並提供了12個月的價格目標。平均目標爲190.29美元，伴隨着最高200.00美元和最低180.00美元的估計。當前的平均值比之前的平均價格目標193.00美元降低了1.4%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
A clear picture of AbbVie's...
通過對最近分...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。